The neurofeedback-based mobile application product Auto Train Brain, which aims to improve the cognitive skills of children and adults experiencing dyslexia, ADHD, and other learning difficulties, has received investment from Pera Yatırım Holding A.Ş. at a valuation of 8.2 million USD. The investment round was completed with a valuation by Trive Yatırım and announced via the Public Disclosure Platform (KAP). With this investment, Auto Train Brain aims to bring its developed technologies to more users and become a global player in the field of neurotechnology.
Developed by HMS Health, Auto Train Brain enhances reading skills and cognitive abilities in children with dyslexia by analyzing brainwaves and providing personalized neurofeedback training programs, thereby supporting brain development. As an EEG-based, AI-powered, and neurofeedback-focused mobile application, Auto Train Brain has been used by approximately 5,000 people to date. Auto Train Brain, as a non-invasive solution with the highest global effect size (0.88), has achieved a net promoter score of 83% among individuals with neurodiversity, particularly those experiencing learning difficulties.
This investment will increase awareness of Neurotechnology in our country!
Auto Train Brain was founded in 2017 under the TÜBİTAK 1512 BİGG Entrepreneurship Support Program at Erciyes Technopark and was supported the same year by Sabancı University Inovent A.Ş. Since 2019, the company has continued its R&D activities at Acıbadem Tekmer. Growing with the technical and academic support it received from Sabancı University, Acıbadem Tekmer, Bahçeşehir University, and TÜBİTAK, Auto Train Brain aims to take its innovative projects one step further with this new investment from Pera Yatırım Holding A.Ş. This investment can be considered a significant milestone in Auto Train Brain's journey to bring its R&D activities and technologies to the global market.
Dr. Günet Eroğlu, CEO of Auto Train Brain, who is a faculty member in the Computer Engineering Department at Bahçeşehir University and conducts scientific research in the field of neurotechnology, shared the following in her statement evaluating the impact of the investment:
"Ten percent of every society has some degree of learning difficulty. Individuals with learning difficulties need an effective and affordable option to reliably and comfortably improve their brain performance. With the mobile application developed by HMS Health, we are enhancing the cognitive abilities of individuals with learning difficulties. Thanks to the investment we received from Pera Yatırım, we are one step closer to our goal of expanding abroad by reaching wider audiences. We sincerely thank Pera Yatırım, Sabancı University, Acıbadem Tekmer, Bahçeşehir University, Erciyes Technopark, KOSGEB, and TÜBİTAK for their support in this process. We believe that these collaborations and supports will play a critical role in increasing the global impact of our technology."
"We believe in Auto Train Brain's patented technology and globalization potential"
Ekrem Korkmaz, Chairman of the Board of Pera Yatırım Holding A.Ş., said in his statement:
"As Pera Yatırım, we aim to invest in high-tech companies, especially those working in the field of artificial intelligence. Our investment in HMS Health's product Auto Train Brain reflects our vision to support future trends in artificial intelligence and neurofeedback technologies. We attach great importance to people-oriented and quality-of-life-enhancing projects in our investments. We believe that with this vision, our investments will positively impact our company's profitability and sustainability, and provide higher returns to our investors. The Auto Train Brain solution has great potential with its advanced technology offerings aimed at improving the cognitive abilities of individuals experiencing learning difficulties. This strategic investment will contribute to the transformation of technology in the fields of health and education. We believe in the product's potential for public offering both domestically and internationally, and we think our collaboration will create exciting opportunities for both our company and the industry's future."
Hakan Kocaman, Chairman of the Board of Trive Yatırım, which conducted the valuation of the investment, stated:
"As Trive Yatırım, we are excited to be part of the investment process of HMS Health. The EEG-based and AI-supported Auto Train Brain product draws attention with its innovative approach in the fields of education and health. This investment reflects the market potential and strategic importance of HMS Health's advanced solutions in technology and neurofeedback. We believe that the investment will enable the company to take firm steps on its growth path and strengthen its leadership in the sector. As Trive Yatırım, we are proud to support such innovative projects and eagerly await their future successes."